TAKEDA PHARMACEUTICA

4502
End-of-day quote. End-of-day quote  - 09/18
3989JPY +0.99%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized around 2 areas:
- sale of drugs and consumer care products;
- sale of services.
Net sales are distributed geographically as follows: Japan (18%), Asia (5%), the United States (48.5%), Europe and Canada (19.6%), Latin America (4.4%), Russia (2.3%) and other (2.2%).

Number of employees : 47 495 people.
Sales per Business
2020
JPY
(in Million)
%
Other 704,76321.4%
Digestive System Diseases 697,89621.2%
Neuroscience 438,52013.3%
Oncology 420,95612.8%
Plasma - Derived Immune Disease Treatment 394,16512%
Rare Blood Disease 334,24010.2%
Rare Metabolic Diseases 170,8255.2%
Hereditary Angioedema 129,8233.9%
Sales per region
20192020
JPY
(in Million)
%JPY
(in Million)
%
United States 828,98539.5% 1,595,92048.5%
Europe and Canada 405,64119.3% 645,52819.6%
Japan 571,01627.2% 592,78618%
Asia 105,4115% 165,4015%
Latin America 88,1154.2% 143,4564.4%
Russia / Commonwealth of Independent States 59,7412.8% 76,8352.3%
Other 38,3151.8% 71,2602.2%
Managers
Name Title
Christophe Weber President, CEO & Representative Director
Constantine Saroukos Chief Financial Officer & Director
Andrew S. Plump Director, Research & Development President
Yasuhiko Yamanaka Director
Masato Iwasaki Director & President-Japan Pharma Business Unit
Masahiro Sakane Independent Outside Director
Shiro Kuniya Independent Outside Director
Yoshiaki Fujimori Independent Outside Director
Emiko Higashi Independent Outside Director
Michel Orsinger Independent Outside Director
Shareholders
Name Equities %
Nomura Asset Management Co., Ltd. 62,258,987 3.95%
Sumitomo Mitsui Trust Asset Management Co., Ltd. 53,210,734 3.38%
BlackRock Fund Advisors 49,607,622 3.15%
The Vanguard Group, Inc. 41,420,275 2.63%
Nippon Life Insurance Co. 35,360,000 2.24%
Nikko Asset Management Co., Ltd. 25,190,300 1.60%
State Street Global Advisors Ltd. 24,727,674 1.57%
Capital Research & Management Co. (World Investors) 24,700,453 1.57%
Mondrian Investment Partners Ltd. 21,444,417 1.36%
Wellington Management Co. LLP 20,289,240 1.29%
Company contact information
1-1 Doshomachi 4-chome
JP-540-8645 Nishi-ku, Osaka


Phone : +81 6 6204 2111
Fax : +81 6 6204 2880
Internet : http://www.takeda.co.jp
Markets and indexes
-
- First Section
- Nikkei 225 / Stoxx Asia Pacific 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  JP3463000004
- Bloomberg Code :  4502:JP
- Reuters Code :  4502.T
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
TAKEDA PHARMACEUTICAL COMPANY LIMITED-5.17%59 719
JOHNSON & JOHNSON2.27%392 765
ROCHE HOLDING AG9.27%322 209
MERCK & CO., INC.-5.65%217 034
PFIZER, INC.-6.02%203 549
NOVARTIS AG-9.76%200 978
NOVO NORDISK A/S12.50%161 415
ABBVIE INC.1.77%159 029
ASTRAZENECA PLC14.97%148 689
AMGEN INC.2.76%145 088
ELI LILLY AND COMPANY17.30%139 751
BRISTOL-MYERS SQUIBB COMPANY-7.66%133 591
SANOFI-1.32%131 820
GLAXOSMITHKLINE PLC-14.24%98 380
CHUGAI PHARMACEUTICAL CO., LTD.40.21%74 167
JIANGSU HENGRUI MEDICINE CO., LTD.22.00%69 460
BAYER AG-21.41%66 692
ALLERGAN PLC0.97%63 659
DAIICHI SANKYO COMPANY, LIMITED33.61%59 941
TAKEDA PHARMACEUTICAL COMPANY LIMITED-7.92%59 719
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED48.84%29 442
Brand Portfolio
INVIRAGEN
INVIRAGEN
SHIRE
SHIRE
TAKEDA
TAKEDA
» More brands of Takeda Pharmaceutical Company Limited